噻托溴铵-仙琚彼多益解析.pptVIP

* 临床症状，尤其是呼吸困难改善良好 * 无论与安慰剂、异丙托溴铵还是沙美特罗对比，噻托溴铵都明显减少了COPD的急性加重次数 * The SGRQ Total score over time for the placebo-controlled trials is illustrated. From 3 months onwards there was a gradual deterioration in quality of life in the placebo group (as shown by the increase in SGRQ Total score). Tiotropium was associated with an improvement in SGRQ over the first 3–6 months that was maintained over the 1-year trial period. The differences between placebo and tiotropium increased over time and were statistically significant at all timepoints. 1 年的SGRQ总评分 与安慰剂对比改善显著，说明噻托溴铵能提高生活质量 SGRQ：圣乔治呼吸调查问